Hypertension Diagnostics PulseWave 510(k) Submission Anticipated This Year
This article was originally published in The Gray Sheet
Executive Summary
Hypertension Diagnostics plans to submit a 510(k) by the end of 1998 for its HDI/PulseWave DO-2020 cardiovascular profiling instrument, the company states in a May 19 filing with the Securities and Exchange Commission for an initial public offering.
You may also be interested in...
Hypertension Diagnostics Plans Second CVProfilor 510(k) Submission By July
Hypertension Diagnostics, Inc. is conducting additional prospective clinical trials of its CVProfilor DO-2020 cardiovascular profiling instrument to support a second 510(k) submission after an initial submission was deemed inadequate by FDA, the firm says. The filing is expected in the first half of this year.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.